Recros Medica Revenue and Competitors
Estimated Revenue & Valuation
- Recros Medica's estimated annual revenue is currently $1.3M per year.
- Recros Medica's estimated revenue per employee is $251,000
Employee Data
- Recros Medica has 5 Employees.
- Recros Medica grew their employee count by -29% last year.
Recros Medica's People
Name | Title | Email/Phone |
---|---|---|
1 | VP, Program Management | Reveal Email/Phone |
2 | VP Clinical Development | Reveal Email/Phone |
3 | SVP, Chief Financial Officer | Reveal Email/Phone |
4 | Director, Quality Assurance | Reveal Email/Phone |
5 | President and CEO | Reveal Email/Phone |
Recros Medica Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $20.3M | 81 | 7% | N/A | N/A |
#2 | $8.5M | 34 | 6% | N/A | N/A |
#3 | $4.5M | 18 | -10% | N/A | N/A |
#4 | $8M | 32 | -6% | N/A | N/A |
#5 | $5.3M | 21 | 0% | N/A | N/A |
#6 | $54.2M | 216 | 9% | N/A | N/A |
#7 | $12M | 48 | N/A | N/A | N/A |
#8 | $10M | 40 | 5% | N/A | N/A |
#9 | $30.1M | 120 | 22% | N/A | N/A |
#10 | $14.1M | 56 | 2% | N/A | N/A |
What Is Recros Medica?
Recros Medica is a pre-commercial stage medical device company developing a new medical aesthetic technology platform (Rotational Fractional Resection). This platform, to be branded Nuvellusâ„¢ Focal Contouring System, provides a minimally invasive surgical application to remove loose skin in improving submental contouring.
keywords:N/AN/A
Total Funding
5
Number of Employees
$1.3M
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Recros Medica News
2022-04-06 - ARS Pharmaceuticals Appoints Eric Karas as Chief ...
... including Neurana Pharmaceuticals, Recros Medica, Adigica Health, Clarify Medical, Oncternal Therapeutics, MDRejuvena and BioSurplus.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.4M | 5 | 0% | N/A |
#2 | $0.4M | 5 | 25% | N/A |
#3 | $0.5M | 5 | -55% | $36M |
#4 | $0.4M | 5 | 0% | N/A |
#5 | $0.4M | 5 | 0% | N/A |